Organogenesis Holdings (ORGO) Interest Coverage Ratio Growth (1y) (2017 - 2026)
Organogenesis Holdings (ORGO) Interest Coverage Ratio Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -83.16% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 128.45% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -97.39% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | -8.29% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Organogenesis Holdings | 238.16 Mn | 191.32 Mn | 20.08 Mn | 1,865.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16,312.95% |
| Mar 31, 2026 | 8,663.01% |
| Dec 31, 2025 | 570.80% |
| Sep 30, 2025 | 2.04% |
| Jun 30, 2025 | 50.31% |
| Mar 31, 2025 | -311.28% |
| Dec 31, 2024 | 271.04% |
| Sep 30, 2024 | 1,316.20% |
| Jun 30, 2024 | -3,025.23% |
| Mar 31, 2024 | -19.70% |
| Dec 31, 2023 | 74.58% |
| Sep 30, 2023 | 390.95% |
| Jun 30, 2023 | -13.14% |
| Mar 31, 2023 | -685.14% |
| Dec 31, 2022 | -112.52% |
| Sep 30, 2022 | -88.55% |
| Jun 30, 2022 | -31.48% |
| Mar 31, 2022 | -101.07% |
| Dec 31, 2021 | -20.76% |
| Sep 30, 2021 | -96.91% |